FrancophonIA/ELRC3.0 huggingface dataset:
English: Intracranial tumours must be inactive and anti-tumour therapy must be completed prior to starting GH therapy.
Slovenian: Intrakranialni tumorji morajo biti nedejavni, zdravljenje tumorja pa se mora končati pred začetkom zdravljenja z rastnim hormonom.
English: Medical treatment for your kidney should be continued.
Slovenian: Zdravljenje ledvic naj se nadaljuje.
English: Patients with growth hormone deficiency are characterised by extracellular volume deficit.
Slovenian: Za bolnike s pomanjkanjem rastnega hormona je značilen primanjkljaj zunajcelične prostornine.
English: If you forget to use Omnitrope
Slovenian: Če ste pozabili vzeti zdravilo Omnitrope
English: Other adverse drug reactions
Slovenian: Drugi neželeni učinki zdravila
English: Omnitrope 5 mg/1.5 ml solution for injection: One ml contains 9 mg benzyl alcohol.
Slovenian: Omnitrope 5 mg/1,5 ml raztopina za injiciranje: En ml vsebuje 9 mg benzilalkohola.
English: Do not share your needles.
Slovenian: Svojih igel ne dajajte drugim.
English: Use with oral oestrogen therapy
Slovenian: Uporaba skupaj s peroralnim estrogenskim zdravljenjem
English: Children with Prader-Willi syndrome:
Slovenian: Otroci s Prader-Willijevim sindromom:
English: In addition, patients already receiving glucocorticoid replacement therapy may need to have the dose of their replacement therapy adjusted, after somatropin treatment is initiated.
Slovenian: Poleg tega pa bo pri bolnikih, ki se že zdravijo z nadomeščanjem glukokortikoidov, po uvedbi zdravljenja s somatropinom morda treba prilagoditi odmerek glukokortikoida pri nadomestnem zdravljenju.
English: The clinical significance of this is unknown.
Slovenian: Klinični pomen tega dejstva ni znan.
English: - Gently swirl the reconstituted vial until the content is completely dissolved.
Slovenian: - Pripravljeno vsebino viale narahlo vrtite, dokler se vsebina povsem ne raztopi.
English: Paraesthesia* Benign intracranial hypertension
Slovenian: Bolezni živčevja parestezija* benigna intrakranialna hipertenzija
English: Taking into account the PRAC Assessment Report on the PSUR(s) for somatropin, the scientific conclusions of CHMP are as follows:
Slovenian: Upoštevajoč poročilo Odbora za oceno tveganja na področju farmakovigilance (PRAC) o oceni rednih posodobljenih poročil o varnosti zdravila (PSUR) za somatropin je Odbor za zdravila za uporabo v humani medicini (CHMP) sprejel naslednje znanstvene zaključke: Vsa zdravila:
English: The injection should be given subcutaneously and the site varied to prevent lipoatrophy.
Slovenian: Zdravilo se injicira subkutano, mesto injiciranja pa se spreminja in tako prepreči pojav lipoatrofije.
English: Therefore, in order to achieve an equivalent clinical and biochemical response compared to men dose adjustments may need to be considered by the prescriber in female patients.
Slovenian: Pri bolnicah bo tako za dosego enakovrednega kliničnega in biokemičnega odziva kot pri moških odmerek morda treba prilagoditi.
English: Somatropin induces the retention of sodium, potassium and phosphorus.
Slovenian: Somatropin povzroči zastajanje natrija, kalija in fosforja v telesu.
English: The very common and common side effects in adults may start within the first months of treatment and may either stop spontaneously or if your dose is reduced.
Slovenian: Ti zelo pogosti in pogosti neželeni učinki pri odraslih se lahko začnejo prve mesece zdravljenja in izzvenijo spontano ali z zmanjšanjem odmerka.
English: Powder and solvent for solution for injection (powder in a vial (5 mg), solvent in a cartridge (1 ml)) Pack sizes of 1 and 5.
Slovenian: Prašek in vehikel za raztopino za injiciranje (prašek v viali (5 mg) in vehikel v vložku (1 ml)) Velikosti pakiranja po 1 in 5.
English: The following is a general description of the administration process.
Slovenian: V nadaljevanju je splošen opis uporabe zdravila.
English: 1 vial of 5 mg powder 1 cartridge of 1 ml solvent 5 vials of 5 mg powder 5 cartridges of 1 ml solvent
Slovenian: 1 viala s 5 mg praška 1 vložek z 1 ml vehikla 5 vial s 5 mg praška 5 vložkov z 1 ml vehikla
English: Use only with Omnitrope Pen L. Read package leaflet before use.
Slovenian: Uporabljajte samo z injekcijskim peresnikom Omnitrope Pen L. Pred uporabo preberite priloženo navodilo!
English: For guidance on dosing see adult section below.
Slovenian: Glejte spodnje smernice za odmerjanje pri odraslih.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Solvent for Omnitrope (water for injections with 1.5% benzyl alcohol) Subcutaneous use.
Slovenian: Vehikel za zdravilo Omnitrope (vode za injekcije z 1,5-odstotnim benzilalkoholom)subkutana uporaba
English: Slipped capital femoral epiphysis and Legg-Calvé-Perthes disease
Slovenian: Zdrs epifize glavice stegnenice in Legg-Calvé-Perthesova bolezen
English: Based on available literature, higher doses of growth hormone are generally required during the initiation and maintenance phases of treatment in women with an intact hypothalamic-pituitarygonadal axis and on oral oestrogens.
Slovenian: Na podlagi razpoložljivih podatkov iz literature so pri ženskah z intaktno osjo hipotalamus-hipofizaspolne žleze, ki se zdravijo s peroralnimi estrogeni, v začetni in vzdrževalni fazi zdravljenja na splošno potrebni večji odmerki rastnega hormona.
English: Measuring the dose of Omnitrope to be injected - Take the sterile, disposable syringe of appropriate size (e.g. 1 ml syringe) and injection needle (e.g. 0.25 mm x 8 mm).
Slovenian: Določanje odmerka zdravila Omnitrope, ki ga je treba injicirati - Vzemite sterilno brizgo primerne velikosti za enkratno uporabo (npr. 1-mililitrsko) in injekcijsko iglo (npr. 0,25 mm x 8 mm).
English: The maintenance dose rarely exceeds 1.0 mg per day.
Slovenian: Dnevni vzdrževalni odmerek redko preseže 1,0 mg na dan.
English: Use only with Omnitrope Pen 10.
Slovenian: Uporabljajte samo z injekcijskim peresnikom Omnitrope Pen 10.
English: - The active substance of Omnitrope is somatropin.
Slovenian: - Zdravilna učinkovina v zdravilu Omnitrope je somatropin.
English: The mean terminal half-life of somatropin after intravenous administration in growth hormone deficient adults is about 0.4 hours.
Slovenian: Pri odraslih s pomanjkanjem rastnega hormona je po intravenski uporabi somatropina srednja končna razpolovna doba okoli 0,4 ure.
English: Long-term treatment of children with growth disturbance due to chronic renal insufficiency System Organ
Slovenian: Dolgotrajno zdravljenje otrok z motnjami v rasti zaradi kronične ledvične insuficience
English: Carbohydrate metabolism
Slovenian: Presnavljanje ogljikovih hidratov
English: The top of the vial and of the cartridge should be wiped with an antiseptic solution in order to prevent contamination of the contents.
Slovenian: Zgornji del viale in vložka obrišite z antiseptično raztopino, da preprečite kontaminacijo vsebine.
English: Leukaemia has been reported in a small number of growth hormone deficiency patients, some of whom have been treated with somatropin.
Slovenian: • levkemija (O njej so poročali pri majhnem številu bolnikov s pomanjkanjem rastnega hormona, pri čemer so bili nekateri zdravljeni s somatropinom.
English: Push up the plunger slowly back to the correct dose.
Slovenian: Bat počasi potiskajte navzgor, dokler ne odmerite pravega odmerka zdravila.
English: However, after subcutaneous administration of Omnitrope powder and solvent for solution for injection, a half-life of 3 hours is achieved.
Slovenian: Po subkutani uporabi zdravila Omnitrope prašek in vehikel za raztopino za injiciranje traja razpolovna doba 3 ure.
English: Higher doses may be necessary if the rate of growth is too low.
Slovenian: Če je stopnja rasti prepočasna, bodo morda potrebni večji odmerki.
English: Somatropin treatment should be stopped at kidney transplantation.
Slovenian: Ob presaditvi ledvic je treba zdravljenje s somatropinom prekiniti.
English: Prader-Willi syndrome, for improvement of growth and body composition in paediatric patients Generally a dose of 0.035 mg/kg body weight per day or 1.0 mg/m2 body surface area per day is recommended.
Slovenian: Prader-Willijev sindrom (PWS), za izboljšanje rasti in sestave telesa pri pediatričnih bolnikih Običajen priporočen odmerek je 0,035 mg/kg telesne mase na dan ali 1,0 mg/m telesne površine na dan.
English: - Turn the vial with the solvent upside down and withdraw all the solvent from the vial.
Slovenian: - Vialo z vehiklom obrnite navzdol in iz nje izčrpajte ves vehikel.
English: - Take the vial with the powder and push the needle through the rubber membrane of the vial.
Slovenian: - Vzemite vialo s praškom in potisnite iglo skozi gumijasto membrano.
English: Use only with Omnitrope Pen 5.
Slovenian: Uporabljajte samo z injekcijskim peresnikom Omnitrope Pen 5.
English: The incidence of these adverse reactions is related to the administered dose, the age of patients, and possibly inversely related to the age of patients at the onset of growth hormone deficiency.
Slovenian: Pogostnost pojava teh neželenih reakcij je odvisna od odmerka zdravila, bolnikove starosti in morda v obratnem sorazmerju z njegovo starostjo ob pojavu pomanjkanja rastnega hormona.
English: Long-term treatment of children with growth disturbance due to insufficient secretion of growth hormone
Slovenian: Dolgotrajno zdravljenje otrok z motnjami v rasti zaradi nezadostnega izločanja rastnega hormona
English: • Store in the original package in order to protect from light.
Slovenian: • Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
English: Patients and caregivers have to receive appropriate training and instruction on the proper use of the Omnitrope vials, the cartridges with solvent, the transfer set and the pen from the physician or other suitable qualified health professionals.
Slovenian: Zdravniki ali drugo ustrezno usposobljeno osebje morajo bolnike in negovalno osebje ustrezno poučiti o pravilni uporabi vial, vložkov s z vehiklom, seta za prenos in peresnika Omnitrope.
English: - Adult onset: Patients who have severe growth hormone deficiency associated with multiple hormone deficiencies as a result of known hypothalamic or pituitary pathology, and who have at least one known deficiency of a pituitary hormone not being prolactin.
Slovenian: Odrasli - Nadomestno zdravljenje odraslih z izrazitim pomanjkanjem rastnega hormona - Začetek v odrasli dobi: bolniki, ki imajo hudo pomanjkanje rastnega hormona, povezano s pomanjkanjem številnih hormonov kot posledica znane bolezni hipotalamusa ali hipofize ter ki imajo pomanjkanje najmanj enega hipofiznega hormona, vendar ne prolaktina; diagnozo pomanjkanja rastnega hormona se pri teh bolnikih potrdi ali ovrže z ustreznim dinamičnim testom.
English: Use only with SurePal 5.
Slovenian: Uporabljajte samo z injekcijskim peresnikom SurePal 5.
English: In children • Stiffness in the arms and legs
Slovenian: Pri otrocih • togost rok in nog
English: Your doctor will show you how to inject Omnitrope.
Slovenian: Zdravnik ali sestra vam bo pokazal, kako si injicirati zdravilo Omnitrope.
English: - Use the transfer set for transferring all the solvent from the cartridge into the vial.
Slovenian: - Vzemite set za prenos, da boste prenesli ves vehikel iz vložka v vialo.
English: Use the transfer set for transferring the solvent from the cartridge into the vial.
Slovenian: Uporabite set za prenos vehikla iz vložka v vialo.
English: Do not use Omnitrope
Slovenian: Ne uporabljajte zdravila Omnitrope
English: - Leave the cartridge in the pen, put the cap on the pen, and store it in the refrigerator.
Slovenian: - Vložek pustite v injekcijskem peresniku, ga zaprite z zaporko in shranite v hladilniku.
English: Children with Prader-Willi syndrome
Slovenian: Otroci s Prader-Willijevim sindromom
English: Pack sizes of 1 and 5.
Slovenian: Velikost pakiranja po 1 in 5.
English: The following instructions explain how to inject Omnitrope 1.3 mg/ml yourself.
Slovenian: Navodila v nadaljevanju pojasnjujejo, kako si lahko sami injicirate zdravilo Omnitrope, 1,3 mg/ml.
English: 1.5 ml of solution in a cartridge (colourless type I glass) with plunger and a blue ring (for Omnitrope 15 mg/1.5 ml solution for injection only) on one side (siliconised bromobutyl), a disc (bromobutyl) and a cap (aluminium) on the other side.
Slovenian: 1,5 ml raztopine v vložku (brezbarvno steklo tipa I) z batom in modrim obročkom (samo za zdravilo Omnitrope 15 mg/1,5 ml raztopine za injiciranje) na eni strani (silikonizirani bromobutil), ploščico (bromobutil) ter zaporko (aluminij) na drugi strani.
English: Use a sterile, disposable syringe (e.g. 2 ml syringe) and needle (e.g. 0.33 mm x 12.7 mm) to withdraw all the solvent from the vial.
Slovenian: Uporabite sterilno injekcijsko brizgo za enkratno uporabo (npr. 2-mililitrsko injekcijsko brizgo) in iglo (npr. 0,33 mm x 12,7 mm), da odstranite ves vehikel iz stekleničke.
English: Inject the solution by pushing the plunger all the way down gently.
Slovenian: Raztopino injicirajte tako, da počasi potiskate bat navzdol do konca.
English: Injecting Omnitrope - Put the cartridge with the dissolved Omnitrope into the pen for injection.
Slovenian: Injiciranje zdravila Omnitrope - Vložek z raztopljenim zdravilom Omnitrope vstavite v peresnik za injiciranje.
English: STATEMENT OF ACTIVE SUBSTANCE Somatropin 6.7 mg (20 IU)/ml.
Slovenian: NAVEDBA ENE ALI VEČ ZDRAVILNIH UČINKOVIN 6,7 mg somatropina (20 i.e.)/ml.
English: 1.5 ml of solution in a cartridge (colourless type I glass) with plunger on one side (siliconised bromobutyl), a disc (bromobutyl) and a cap (aluminium) on the other side.
Slovenian: 1,5 ml raztopine v vložku (brezbarvno steklo tipa I) z batom na eni strani (silikonizirani bromobutil), ploščico (bromobutil) ter zaporko (aluminij) na drugi strani.
English: Rarely, an inflammation of the pancreas has been reported in patients treated with growth hormone.
Slovenian: Redko so pri bolnikih, zdravljenih z rastnim hormonom, poročali o vnetju trebušne slinavke.
English: The active substance of Omnitrope is somatropin.
Slovenian: Zdravilna učinkovina v zdravilu Omnitrope je somatropin.
English: and injection needle (e.g. 0.25 mm x 8 mm) for subcutaneous injection (not supplied in the pack).
Slovenian: (npr. 1-mililitrsko) in injekcijsko iglo (npr. 0,25 mm x 8 mm) za subkutano injiciranje (ki je ni v ovojnini) - 2 blazinici iz vate za čiščenje (ki ju ni v ovojnini).
English: - Take the vial with solvent and the sterile, disposable syringe (e.g. 2 ml syringe) and needle (e.g. 0.33 mm x 12.7 mm).
Slovenian: - Vzemite vialo z vehiklom in sterilno injekcijsko brizgo za enkratno uporabo (npr. 2-mililitrsko) ter iglo (npr. 0,33 mm x 12,7 mm).
English: The following instructions explain how to inject Omnitrope 5 mg/ml yourself.
Slovenian: Navodila v nadaljevanju pojasnjujejo, kako si lahko sami injicirate zdravilo Omnitrope, 5 mg/ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Solvent for Omnitrope (water for injections) Subcutaneous use.
Slovenian: Vehikel za zdravilo Omnitrope (voda za injekcije) subkutana uporaba
English: All patients with PWS should be evaluated for sleep apnoea and monitored if sleep apnoea is suspected.Patients should be monitored for signs of respiratory infections, which should be diagnosed as early as possible and treated aggressively.
Slovenian: Pri vseh bolnikih je treba biti pozoren na morebitne znake okužbe dihal, jih čim prej diagnosticirati in agresivno zdraviti.
English: The solution is for single use only.
Slovenian: Raztopina je le za enkratno uporabo.
English: Patients and caregivers have to receive appropriate training and instruction on the proper use of the Omnitrope cartridges and the pen from the physician or other suitable qualified health professionals.
Slovenian: Zdravniki ali drugo ustrezno usposobljeno osebje morajo bolnike in negovalno osebje ustrezno poučiti o pravilni uporabi vložkov in injekcijskega peresnika Omnitrope.
English: How to use Omnitrope
Slovenian: Kako uporabljati zdravilo Omnitrope
English: Testing for antibodies to somatropin should be carried out in any patient with otherwise unexplained lack of response.
Slovenian: Sposobnost vezave teh protiteles je majhna in učinka na stopnjo rasti ni. Testiranje za protitelesa za somatropin je treba opraviti pri vseh bolnikih, pri katerih pomanjkanja odziva ni mogoče pojasniti na drugačen način.
English: The manufacturer's instructions with each pen must be followed for loading the cartridge, attaching the injection needle and for the administration.
Slovenian: Izdelovalčeva navodila, ki so priložena injekcijskemu peresniku, je treba upoštevati pri polnjenju vložka, pritrditvi injekcijske igle in pri uporabi.
English: Very common side effects (likely to occur in more than 1 in 10 patients) include: In adults
Slovenian: Zelo pogosti neželeni učinki (pojavijo se lahko pri več kot 1 od 10 bolnikov) vključujejo: Pri odraslih
English: Omnitrope 5 mg/ml is supplied in a vial containing the active substance as a powder and the solvent filled in a cartridge.
Slovenian: Omnitrope 5 mg/ml je v viali, ki vsebuje zdravilno učinkovino v obliki praška in vehikel v vložku.
English: - After reconstitution, Omnitrope is given as an injection under the skin.
Slovenian: - Po pripravi se zdravilo Omnitrope injicira pod kožo.
English: However, after subcutaneous administration of Omnitrope 5 mg/1.5 ml, Omnitrope 10 mg/1.5 ml solution for injection, a half-life of 3 hours is achieved.
Slovenian: Po subkutani uporabi zdravila Omnitrope 5 mg/1,5 ml, Omnitrope 10 mg/1,5 ml raztopina za injiciranje traja razpolovna doba 3 ure.
English: Although rare, pancreatitis should be considered in somatropin-treated children who develop abdominal pain.
Slovenian: Primeri so sicer redki, vendar pa je pri otroku, ki se zdravi s somatropinom, v primeru pojava bolečine v trebuhu treba pomisliti na pankreatitis.
English: An increased chromosome fragility has been observed in one in vitro study on lymphocytes taken from patients after long term treatment with somatropin and following the addition of the radiomimetic drug bleomycin.
Slovenian: V preskušanju in vitro na limfocitih, ki so jih odvzeli bolnikom, ki so se dolgo časa zdravili s somatropinom in poleg tega jemali radiomimetično zdravilo bleomicin, se je zvečala krhkost kromosomov.
English: - Be sure that the tip of the syringe is in the Omnitrope reconstituted solution.
Slovenian: - Prepričajte se, da je konica injekcijske brizge v pripravljeni raztopini zdravila Omnitrope.
English: This will keep the Omnitrope solution sterile and prevent leaking.
Slovenian: Tako bo raztopina Omnitrope ostala sterilna in ne bo odtekala.
English: • Numbness/tingling
Slovenian: • otopelost/ščemenje
English: Assemble the pen following the instructions for use.
Slovenian: Peresnik sestavite tako, kot piše v navodilih za uporabo.
English: In adults Omnitrope is used to
Slovenian: Zdravilo Omnitrope se uporablja pri odraslih za
English: However, after subcutaneous administration of Omnitrope 15 mg/1.5 ml solution for injection, a half life of 2.76 hours is achieved.
Slovenian: Po subkutani uporabi zdravila Omnitrope 15 mg/1,5 ml raztopina za injiciranje traja razpolovna doba 2,76 ure.
English: Other ingredients:
Slovenian: Pomožne snovi:
English: The glass cartridge is irreversibly integrated in a transparent container and assembled to a plastic mechanism with a threaded rod at one extremity.
Slovenian: Stekleni vložek je neločljivo vgrajen v prozoren vsebnik; na eni strani ima nameščen plastičen mehanizem z nazobčanim potisnikom.
English: Powder in a vial (type I glass) with a stopper (fluor-resin laminated butyl rubber), a strip (aluminium) and a cap (green polypropylene flip-off), and 1 ml of solvent in a cartridge (type I glass) with a stopper (fluor-resin laminated chlorobutyl elastomer), a strip (lacquered aluminium) and a cap (white polypropylene flip-off).
Slovenian: Prašek v viali (steklo tipa I) z zamaškom (butilkavčuk, laminiran s fluorovo smolo), trak (aluminij) in zaporko (zelena odtržna zaporka iz polipropilena) in 1 ml vehikla v vložku (steklo tipa I) z zamaškom (klorobutilelastomer, laminiran s fluorovo smolo), trakom (lakirani aluminij) ter zaporko (bela odtržna zaporka iz polipropilena).
English: Growth disturbance due to insufficient secretion of growth hormone in paediatric patients Generally a dose of 0.025 - 0.035 mg/kg body weight per day or 0.7 - 1.0 mg/m2 body surface area per day is recommended.
Slovenian: Motnje rasti zaradi nezadostnega izločanja rastnega hormona pri pediatričnih bolnikih Običajen priporočen odmerek je 0,025 do 0,035 mg/kg telesne mase na dan ali 0,7 do 1,0 mg/m telesne površine na dan.
English: The solvent is clear and colourless.
Slovenian: Raztopina je bistra in brezbarvna.
English: - The contents must be clear and colourless.
Slovenian: - Vsebina mora biti bistra in brezbarvna.
English: - Insert the cartridge into the pen for injection.
Slovenian: - Vložek vstavite v peresnik za injiciranje.
English: Clean the injection site with an alcohol swab and administer Omnitrope by subcutaneous injection.
Slovenian: Mesto injiciranja očistite z blazinico iz vate, namočeno v alkohol, in injicirajte zdravilo Omnitrope subkutano.
English: Push the needle fitted to the syringe through the rubber membrane.
Slovenian: Iglo na injekcijski brizgi potisnite skozi gumijasto membrano.
English: Powder in a vial (type I glass) with a stopper (fluor-resin laminated butyl rubber), a strip (aluminium) and a cap (violet polypropylene flip-off), and 1 ml of solvent in a vial (type I glass) with a stopper (fluor-resin laminated chlorobutyl elastomer), a strip (lacquered aluminium) and a cap (white polypropylene flip-off).
Slovenian: Prašek v viali (steklo tipa I) z zamaškom (butilkavčuk, laminiran s fluorovo smolo), trakom (aluminij) in zaporko (vijoličasta odtržna zaporka iz polipropilena) in 1 ml vehikla v viali (steklo tipa I) z zamaškom (klorobutilelastomer, laminiran s fluorovo smolo), trakom (lakirani aluminij) ter zaporko (bela odtržna zaporka iz polipropilena).
English: Injecting Omnitrope
Slovenian: Injiciranje zdravila Omnitrope
English: For patients with diabetes mellitus, the insulin dose may require adjustment after somatropin therapy is instituted.
Slovenian: Pri bolnikih s sladkorno boleznijo bo morda treba po začetku zdravljenja s somatropinom prilagoditi odmerek insulina.
English: Clinical trials in adults with GHD
Slovenian: Klinična preskušanja pri odraslih s PRH
English: Rare side effects (likely to occur in fewer than 1 in 1,000 patients) include: In children
Slovenian: Redki neželeni učinki (pojavijo se lahko pri največ 1 od 1.000 bolnikov) vključujejo: Pri otrocih
English: Children with Turner syndrome: 0.045-0.050 mg/kg body weight per day or 1.4 mg/m2 body surface area per day.
Slovenian: Otroci s Turnerjevim sindromom: 0,045-0,050 mg/kg telesne mase na dan ali 1,4 mg/m telesne površine na dan.
English: Omnitrope 1.3 mg/ml is supplied in a vial containing the active substance as a powder and the solvent filled in a vial for single use.
Slovenian: Omnitrope 1,3 mg/ml je v viali za enkratno uporabo, ki vsebuje zdravilno učinkovino v obliki praška in vehikel.
English: Store in the original pen in order to protect from light.
Slovenian: Shranjujte v originalni ovojnini za zagotovitev zaščite pred svetlobo.
English: In general these adverse reactions are mild to moderate, arise within the first months of treatment and subside spontaneously or with dose-reduction.
Slovenian: Ponavadi so reakcije blage do zmerne, pojavijo se v prvih mesecih zdravljenja, izginejo pa sami od sebe ali po zmanjšanju odmerka.
English: The content must be clear and colourless.
Slovenian: Vsebina mora biti bistra in brezbarvna.
English: Omnitrope 10 mg/1.5 ml solution for injection 18 months.
Slovenian: Omnitrope 10 mg/1,5 ml raztopina za injiciranje 18 mesecev.
English: How to inject Omnitrope 1.3 mg/ml
Slovenian: Kako si je treba injicirati zdravilo Omnitrope 1,3 mg/ml
English: Omnitrope 15 mg/1.5 ml solution for injection 18 months.
Slovenian: Omnitrope 15 mg/1,5 ml raztopina za injiciranje 18 mesecev.